Skip to content

A clinical trial study of a traditional Chinese medicine prescription combined with balance acupuncture in the treatment of migraine

A clinical trial study of a traditional Chinese medicine prescription combined with balance acupuncture in the treatment of migraine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005174
Enrollment
Unknown
Registered
2021-08-15
Start date
2021-08-15
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

migraine

Interventions

Sponsors

Affiliated Hospital of Changchun University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Meet the diagnostic criteria of Western medicine for migraine (migraine with aura or migraine without aura); 2.Patients who meet the diagnostic criteria of liver-yang hyperactivity syndrome based on TCM differentiation; 3.4 points <= VAS score <= 8 points, which affects work and study; 4.For 3 months, the number of headache attacks every 4 weeks without aura migraine is more than 5 times (including 5 times); migraine with aura is more than 2 times (including 2 times); 5.The age is between 18 and 65 years old; the age of first onset is =50 years old; 6.The patient gave informed consent and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Headache, but as a symptom of other diseases, such as hypertensive headache, cerebral hemorrhage brain disease, post-traumatic headache, intracranial low pressure headache, headache caused by intracranial space-occupying lesions, and ENT eye , Ear, nose, and paranasal sinus disease accompanied by headache, poisoning, febrile and other headaches; 2.Special types of migraine, such as ophthalmoplegia, hemiplegic migraine, basilar artery migraine, etc.; 3.Other types of headaches such as tension-type headaches, cluster headaches and neurotic headaches; 4.Those who take painkillers or who are dependent on painkillers during the trial period; 5.Take medicines that may have the effect of preventing and curing headache attacks (such as sibilene, nimodipine, etc.) for 3 months; 6.Patients with severe cardiopulmonary insufficiency, severe primary diseases such as liver, kidney, hematopoietic system, mental illness, gastrointestinal diseases that seriously affect drug absorption; 7.Patients who have used antipsychotics or antidepressants 3 months before the test; 8.Suspected or true history of alcohol or drug abuse, or other diseases or conditions that reduce the possibility of enrollment or complicate enrollment according to the judgment of the investigator, such as frequent changes in the working environment and cause loss to follow-up.

Design outcomes

Primary

MeasureTime frame
Headache measure;

Countries

China

Contacts

Public ContactLiu Liming

Affiliated Hospital of Changchun University of Traditional Chinese Medicine

llm1226@163.com+86 15948053707

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026